Lesley Ann Calhoun

CIK: 0001730866

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TNGX

Tango Therapeutics, Inc.

Director

ALGS

Aligos Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TNGX
Tango Therapeutics, Inc.
Jun 5, 2026
Award(A)
Direct
4K shares-
ALGS
Aligos Therapeutics, Inc.
Mar 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
37.5K shares-
ALGS
Aligos Therapeutics, Inc.
Jul 16, 2025
Award(A)
Stock Option (Right to Buy)
Direct
40.2K shares-
TNGX
Tango Therapeutics, Inc.
Jun 5, 2025
Award(A)
Direct
6.3K shares-
ALGS
Aligos Therapeutics, Inc.
Feb 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
47.3K shares-
ALGS
Aligos Therapeutics, Inc.
Sep 4, 2024
Award(A)
Stock Option (Right to Buy)
Direct
10.9K shares-

		Type	Shares	Price		Ownership
Jun 5, 2026	TNGX Tango Therapeutics, Inc.	Award(A)	4,000	-	$0	Direct
Mar 9, 2026	ALGS Aligos Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	37,485	-	-	Direct
Jul 16, 2025	ALGS Aligos Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	40,185	-	-	Direct
Jun 5, 2025	TNGX Tango Therapeutics, Inc.	Award(A)	6,250	-	-	Direct
Feb 28, 2025	ALGS Aligos Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	47,271	-	-	Direct
Sep 4, 2024	ALGS Aligos Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	10,880	-	-	Direct

1-6 of 6 transactions

About Calhoun Lesley Ann

Calhoun Lesley Ann (SEC CIK 0001730866) files insider reports with the SEC as Director of Tango Therapeutics, Inc. (TNGX) and Officer of Aligos Therapeutics, Inc. (ALGS).

Signal8 holds 6 ownership filings by Calhoun Lesley Ann, all Form 4s, filed between Sep 6, 2024 and Jun 8, 2026. Those filings report 6 transactions, from Sep 4, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Calhoun Lesley Ann's filings is in BOSTON, MA.

Recent filings by Calhoun Lesley Ann

Jun 5, 2026: Grant or award of TNGX shares (Form 4, code A).
Mar 9, 2026: Grant or award of ALGS derivative securities (Form 4, code A).
Jul 16, 2025: Grant or award of ALGS derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of TNGX shares (Form 4, code A).
Feb 28, 2025: Grant or award of ALGS derivative securities (Form 4, code A).

Other insiders filing for Tango Therapeutics, Inc. (TNGX)

Crystal Adam, President, R&D
Newcomb Jessica, Principal Accounting Officer
Azelby Robert, Director
Ketchum John B, Director
Rothenberg Mace, Director
Lee Sung, Director

How to read Form 4 transaction codes